Pharma Co. Beats Investor Suit Over Licensing Agreement
By Sydney Price · February 9, 2024, 8:37 PM EST
A New York federal judge has dismissed a proposed investor class action against pharmaceutical company Molecular Partners, ruling the plaintiff failed to show the company misled investors about its progress in...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login